FDA Approved Medical Products for:

Cryopyrin-associated periodic syndrome

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Ilaris
Trade Name
(Manufacturer Name)
Canakinumab
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older. Also approved for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.
More Information about this product Drug Information Portal